TKT and neoplasm: This difference could be due to the higher gene transduction efficiency of tk-VLPs being mixed with and thus being in close contact with the tumor cells, or the superior tumor-inhibitory effect of giving the tk-VLPs/GCV treatment early, before the implanted tumor had a chance to grow.